Revenue Projections | GYROSTIM

top of page

Designated by the FDA as a Breakthrough Medical Device

719-685-7883

GRAsset 2titles.png

Gyrostim REV ProJ 25.png

Research on GyroStim and concussion is underway. Stay up to date on our progress through the FDA process.

Email*

What is your primary interest in GyroStim?*

State or Country & City*

badge_IVeDA IAC.png

GyroStim is proud to be a member of the Vestibular Disorders Association's (VeDA) Industry Advisory Council.

GyroStim is FDA-cleared for use in the treatment of balance disorders and vestibular dysfunction.

GyroStim is a product of UltraThera Technologies, Inc.

and is protected by multiple patents, copyrights, and trademarks.

2 North Cascade Avenue / Suite 1320

Colorado Springs, CO 80903

inquiries@gyrostim.com

©2024 UltraThera Technologies, Inc.

bottom of page

Web Analytics